BIOMAT Database Logo BIOMAT Database Logo

Clinical trial with oxamniquine and praziquantel in the acute and chronic phases of schistosomiasis mansoni. 1983

N Katz, and R S Rocha, and J R Lambertucci, and D B Greco, and E R Pedroso, and M O Rocha, and S Flan

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D009600 Nitroquinolines Quinolines substituted in any position by one or more nitro groups.
D010073 Oxamniquine An anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. (From Martindale, The Extra Pharmacopoeia, 31st ed, p121) Oxaminiquine,UK-4271,UK 4271,UK4271
D010270 Parasite Egg Count Determination of parasite eggs in feces. Count, Parasite Egg,Counts, Parasite Egg,Egg Count, Parasite,Egg Counts, Parasite,Parasite Egg Counts
D011223 Praziquantel An anthelmintic used in most schistosome and many cestode infestations. Biltricide,Cesol,Cisticid,Cysticide,Droncit,Drontsit,EMBAY 8440,Prasiquantel,Praziquantel, (+-)-Isomer,Praziquantel, (R)-Isomer,Praziquantel, (S)-Isomer,Pyquiton,Traziquantel
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

N Katz, and R S Rocha, and J R Lambertucci, and D B Greco, and E R Pedroso, and M O Rocha, and S Flan
Double-blind clinical trial comparing praziquantel with oxamniquine in the treatment of patients with schistosomiasis mansoni.
January 1982, Revista do Instituto de Medicina Tropical de Sao Paulo,
N Katz, and R S Rocha, and J R Lambertucci, and D B Greco, and E R Pedroso, and M O Rocha, and S Flan
Treatment of patients with schistosomiasis mansoni: a double blind clinical trial comparing praziquantel with oxamniquine.
January 1986, Revista do Instituto de Medicina Tropical de Sao Paulo,
N Katz, and R S Rocha, and J R Lambertucci, and D B Greco, and E R Pedroso, and M O Rocha, and S Flan
Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni.
August 2008, Memorias do Instituto Oswaldo Cruz,
N Katz, and R S Rocha, and J R Lambertucci, and D B Greco, and E R Pedroso, and M O Rocha, and S Flan
Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni.
December 2008, Memorias do Instituto Oswaldo Cruz,
N Katz, and R S Rocha, and J R Lambertucci, and D B Greco, and E R Pedroso, and M O Rocha, and S Flan
A double blind trial with oxamniquine in chronic schistosomiasis mansoni.
January 1982, Transactions of the Royal Society of Tropical Medicine and Hygiene,
N Katz, and R S Rocha, and J R Lambertucci, and D B Greco, and E R Pedroso, and M O Rocha, and S Flan
Survey on the clinical trial results achieved in Brazil comparing praziquantel and oxamniquine in the treatment of mansoni schistosomiasis.
January 1985, Revista do Instituto de Medicina Tropical de Sao Paulo,
N Katz, and R S Rocha, and J R Lambertucci, and D B Greco, and E R Pedroso, and M O Rocha, and S Flan
[Low effectiveness of an oxamniquine and praziquantel combination in the therapy of schistosomiasis mansoni].
January 1986, Revista da Sociedade Brasileira de Medicina Tropical,
N Katz, and R S Rocha, and J R Lambertucci, and D B Greco, and E R Pedroso, and M O Rocha, and S Flan
Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi.
January 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene,
N Katz, and R S Rocha, and J R Lambertucci, and D B Greco, and E R Pedroso, and M O Rocha, and S Flan
Combined praziquantel-oxamniquine treatment of schistosomiasis.
January 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene,
N Katz, and R S Rocha, and J R Lambertucci, and D B Greco, and E R Pedroso, and M O Rocha, and S Flan
Efficacy of oxamniquine, praziquantel and a combination of both drugs in schistosomiasis mansoni in Brazil.
January 1987, Revista do Instituto de Medicina Tropical de Sao Paulo,
Copied contents to your clipboard!